O’Melveny’s Representation of Pharmaron Noted in Pharmabiz

February 05, 2016

The February 5, 2016, article, “Pharmaron Buys UK-based CRO, Quotient Bioresearch,” notes O’Melveny’s representation of Pharmaron in its acquisition of Quotient Bioresearch. Pharmaron is a fully integrated CRO offering laboratory and manufacturing services for pharmaceutical and biotech research and development.